These findings suggest that in our cognitively unimpaired cohort enriched by APOE ε4 carriers, neuroinflammatory processes measured by TSPO PET are related to a more advanced preclinical phase of AD where Aβ accumulation is accompanied by subtle structural changes. Here, TSPO is linked to Alzheimer disease.